Cargando…

Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells

BACKGROUND: Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34(+ )AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34(- )AML cells. Curcumin is a major component of turmeric that...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Jia, Xu, Duo-Rong, Zheng, Fei-Meng, Long, Zi-Jie, Huang, Sheng-Shan, Wu, Xing, Zhou, Wei-Hua, Huang, Ren-Wei, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118333/
https://www.ncbi.nlm.nih.gov/pubmed/21595920
http://dx.doi.org/10.1186/1479-5876-9-71
_version_ 1782206458768654336
author Rao, Jia
Xu, Duo-Rong
Zheng, Fei-Meng
Long, Zi-Jie
Huang, Sheng-Shan
Wu, Xing
Zhou, Wei-Hua
Huang, Ren-Wei
Liu, Quentin
author_facet Rao, Jia
Xu, Duo-Rong
Zheng, Fei-Meng
Long, Zi-Jie
Huang, Sheng-Shan
Wu, Xing
Zhou, Wei-Hua
Huang, Ren-Wei
Liu, Quentin
author_sort Rao, Jia
collection PubMed
description BACKGROUND: Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34(+ )AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34(- )AML cells. Curcumin is a major component of turmeric that has shown cytotoxic activity in multiple cancers; however, its anti-cancer activity has not been well studied in DNR-insensitive CD34(+ )AML cells. The aim of this study was to therefore to explore curcumin-induced cytotoxicity in DNR-insensitive CD34(+ )AML cell lines (KG1a, Kasumi-1), DNR-sensitive U937 AML cells, and primary CD34(+ )AML bone-marrow-derived cells. METHODS: Primary human CD34(+ )cells were isolated from peripheral blood mononuclear cells or bone marrow mononuclear cells using a CD34 MicroBead kit. The growth inhibitory effects of curcumin were evaluated by MTT and colony-formation assays. Cell cycle distribution was examined by propidium iodide (PI) assay. Apoptosis was analyzed by Wright-Giemsa, Hoechst 33342 and Annexin-V/PI staining assays. The change in mitochondrial membrane potential (MMP) was examined by JC-1 staining and flow cytometry. Expression of apoptosis-related proteins was determined by reverse transcription-polymerase chain reaction and Western blotting. Short interfering RNA (siRNA) against Bcl-2 was used in CD34(+ )KG1a and Kasumi-1 cells incubated with/without DNR. RESULTS: Curcumin inhibited proliferation and induced apoptosis and G1/S arrest in both DNR-insensitive KG1a, Kasumi-1 and DNR-sensitive U937 cells. Curcumin-induced apoptosis was associated with reduced expression of both Bcl-2 mRNA and protein, subsequent loss of MMP, and activation of caspase-3 followed by PARP degradation. Curcumin synergistically enhanced the cytotoxic effect of DNR in DNR-insensitive KG1a and Kasumi-1 cells, consistent with decreased Bcl-2 expression. Accordingly, siRNA against Bcl-2 increased the susceptibility of KG1a and Kasumi-1 cells to DNR-induced apoptosis. More importantly, curcumin suppressed Bcl-2 expression, selectively inhibited proliferation and synergistically enhanced the cytotoxicity of DNR in primary CD34(+ )AML cells, while showing limited lethality in normal CD34(+ )hematopoietic progenitors. CONCLUSION: Curcumin down-regulates Bcl-2 and induces apoptosis in DNR-insensitive CD34(+ )AML cell lines and primary CD34(+ )AML cells.
format Online
Article
Text
id pubmed-3118333
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31183332011-06-20 Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells Rao, Jia Xu, Duo-Rong Zheng, Fei-Meng Long, Zi-Jie Huang, Sheng-Shan Wu, Xing Zhou, Wei-Hua Huang, Ren-Wei Liu, Quentin J Transl Med Research BACKGROUND: Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34(+ )AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34(- )AML cells. Curcumin is a major component of turmeric that has shown cytotoxic activity in multiple cancers; however, its anti-cancer activity has not been well studied in DNR-insensitive CD34(+ )AML cells. The aim of this study was to therefore to explore curcumin-induced cytotoxicity in DNR-insensitive CD34(+ )AML cell lines (KG1a, Kasumi-1), DNR-sensitive U937 AML cells, and primary CD34(+ )AML bone-marrow-derived cells. METHODS: Primary human CD34(+ )cells were isolated from peripheral blood mononuclear cells or bone marrow mononuclear cells using a CD34 MicroBead kit. The growth inhibitory effects of curcumin were evaluated by MTT and colony-formation assays. Cell cycle distribution was examined by propidium iodide (PI) assay. Apoptosis was analyzed by Wright-Giemsa, Hoechst 33342 and Annexin-V/PI staining assays. The change in mitochondrial membrane potential (MMP) was examined by JC-1 staining and flow cytometry. Expression of apoptosis-related proteins was determined by reverse transcription-polymerase chain reaction and Western blotting. Short interfering RNA (siRNA) against Bcl-2 was used in CD34(+ )KG1a and Kasumi-1 cells incubated with/without DNR. RESULTS: Curcumin inhibited proliferation and induced apoptosis and G1/S arrest in both DNR-insensitive KG1a, Kasumi-1 and DNR-sensitive U937 cells. Curcumin-induced apoptosis was associated with reduced expression of both Bcl-2 mRNA and protein, subsequent loss of MMP, and activation of caspase-3 followed by PARP degradation. Curcumin synergistically enhanced the cytotoxic effect of DNR in DNR-insensitive KG1a and Kasumi-1 cells, consistent with decreased Bcl-2 expression. Accordingly, siRNA against Bcl-2 increased the susceptibility of KG1a and Kasumi-1 cells to DNR-induced apoptosis. More importantly, curcumin suppressed Bcl-2 expression, selectively inhibited proliferation and synergistically enhanced the cytotoxicity of DNR in primary CD34(+ )AML cells, while showing limited lethality in normal CD34(+ )hematopoietic progenitors. CONCLUSION: Curcumin down-regulates Bcl-2 and induces apoptosis in DNR-insensitive CD34(+ )AML cell lines and primary CD34(+ )AML cells. BioMed Central 2011-05-19 /pmc/articles/PMC3118333/ /pubmed/21595920 http://dx.doi.org/10.1186/1479-5876-9-71 Text en Copyright ©2011 Rao et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rao, Jia
Xu, Duo-Rong
Zheng, Fei-Meng
Long, Zi-Jie
Huang, Sheng-Shan
Wu, Xing
Zhou, Wei-Hua
Huang, Ren-Wei
Liu, Quentin
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
title Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
title_full Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
title_fullStr Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
title_full_unstemmed Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
title_short Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
title_sort curcumin reduces expression of bcl-2, leading to apoptosis in daunorubicin-insensitive cd34(+ )acute myeloid leukemia cell lines and primary sorted cd34(+ )acute myeloid leukemia cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118333/
https://www.ncbi.nlm.nih.gov/pubmed/21595920
http://dx.doi.org/10.1186/1479-5876-9-71
work_keys_str_mv AT raojia curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT xuduorong curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT zhengfeimeng curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT longzijie curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT huangshengshan curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT wuxing curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT zhouweihua curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT huangrenwei curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells
AT liuquentin curcuminreducesexpressionofbcl2leadingtoapoptosisindaunorubicininsensitivecd34acutemyeloidleukemiacelllinesandprimarysortedcd34acutemyeloidleukemiacells